<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01181661</url>
  </required_header>
  <id_info>
    <org_study_id>1R21DA029162</org_study_id>
    <secondary_id>1R21DA029162</secondary_id>
    <nct_id>NCT01181661</nct_id>
  </id_info>
  <brief_title>Internet-based Group Contingency Management to Promote Smoking Abstinence</brief_title>
  <official_title>Internet-based Group Contingency Management to Promote Smoking Abstinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Development and Research Institutes, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>National Development and Research Institutes, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to develop and test an Internet-based group contingency
      management program designed to promote smoking cessation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Breath CO</measure>
    <time_frame>8 weeks</time_frame>
    <description>Twice daily breath CO samples obtained during baseline and treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Point prevalence measure of abstinence</measure>
    <time_frame>at the end of treatment (approximately week 4) and at 3 month follow-up</time_frame>
    <description>Abstinence will be defined as: (a) CO sample ≤ 4 ppm; (b) cotinine &lt; 50 ng/ml; and (c) reporting not smoking, not even a puff in the last 7 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of abstinence during treatment.</measure>
    <time_frame>3 weeks</time_frame>
    <description>The longest duration of sustained abstinence (CO ≤ 4 ppm) based on the twice-daily breath samples during the treatment period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of social exchanges</measure>
    <time_frame>3 weeks</time_frame>
    <description>The number of comments posted on the discussion forum during treatment.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Cigarette Smoking</condition>
  <arm_group>
    <arm_group_label>Full Group Contingency</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group (n = 20) will earn vouchers based only on team (n = 4) performance. Only if all members of the team submit a negative sample (CO ≤ 4 ppm), will they each earn a voucher.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mixed Group Contingency</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group (n = 20) will earn vouchers based on both individual and team (n = 4) performance. If an individual submits a negative sample (CO ≤ 4 ppm), s/he will earn a voucher. Additionally, bonus vouchers will be earned if all team members submit negative samples.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Full Group Contingency</intervention_name>
    <description>This group (n = 20) will earn vouchers based only on team (n = 4) performance. Only if all members of the team submit a negative sample (CO ≤ 4 ppm), will they each earn a voucher.</description>
    <arm_group_label>Full Group Contingency</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mixed Group Contingency</intervention_name>
    <description>This group (n = 20) will earn vouchers based on both individual and team (n = 4) performance. If an individual submits a negative sample (CO ≤ 4 ppm), s/he will earn a voucher. Additionally, bonus vouchers will be earned if all team members submit negative samples.</description>
    <arm_group_label>Mixed Group Contingency</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  self-reported smoker

          -  ability to use the Internet

          -  permission to contact applicant by phone

        Exclusion Criteria:

          -  self-report of a history of or current severe or unstable medical or psychiatric
             illness that would interfere with the study

          -  inability to avoid high levels of ambient CO (e.g., occupational exposure; lives with
             a another smoker who smokes in the home)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jesse Dallery, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Development and Research Institutes, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Development and Research Institutes</name>
      <address>
        <city>New York City</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2010</study_first_submitted>
  <study_first_submitted_qc>August 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2010</study_first_posted>
  <last_update_submitted>September 23, 2014</last_update_submitted>
  <last_update_submitted_qc>September 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Development and Research Institutes, Inc.</investigator_affiliation>
    <investigator_full_name>Jesse Dallery</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Cigarette</keyword>
  <keyword>Smoking</keyword>
  <keyword>Nicotine</keyword>
  <keyword>Contingency Management</keyword>
  <keyword>Voucher Reinforcement</keyword>
  <keyword>Smoking Abstinence</keyword>
  <keyword>Internet</keyword>
  <keyword>Internet-based Treatment</keyword>
  <keyword>Group Contingencies</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

